According to a recent study published June 20 in the Journal of the American College of Cardiology, more than 1/3 of patients in atrial fibrillation are not receiving sufficient anti-coagulation.   Many of these patients are receiving only aspirin instead of a more effective blood thinner like warfarin, or one of the newer anti-coagulant drugs like Pradaxa or  Xarelto.